Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Medical Cannabis and Cannabinoids is Scopus-indexed (Q1, CiteScore 5), DOAJ. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 2504-3889Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Complementary and Alternative Medicine | 28 / 115 | 76th | Q1 |
| Pharmacology (medical) | 100 / 278 | 64th | Q2 |
| Pharmacology | 141 / 328 | 57th | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q1, CiteScore 5.
Medical Cannabis and Cannabinoids is Q1 in Complementary and Alternative Medicine (rank 28 of 115), Q2 in Pharmacology (medical) (rank 100 of 278) and Q2 in Pharmacology (rank 141 of 328), by CiteScore 2025.
Medical Cannabis and Cannabinoids is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5, quartile Q1, 76th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.705, quartile Q1, with an H-index of 19.
The publisher lists an article processing charge of about US$990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Medical Cannabis and Cannabinoids is published by S. Karger AG. Its ISSN is 2504-3889.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Medical Cannabis and Cannabinoids has an h-index of 24 and a 2-year mean of 4.14 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q1. On 2-year citations it ranks #10 of 109 Scopus journals in Complementary and Alternative Medicine.
Medical Cannabis and Cannabinoids published 17 papers in 2025; its busiest recent year was 2024 with 28. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 94 research articles (2021–2026), authors are most often from United States (63.7%), United Kingdom (3.9%) and Thailand (3.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.